[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium

C132H252N32+2 — CID 18671065

IUPAC[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium
SMILESCCCCN(CCCNc1nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)n1)c1nc(NCCNc2nc(N(CCCC)CCCNc3nc(N(CCCC)C4CC(C)(C)N(C)C(C)(C)C4)nc(N(CCCC)C4CC(C)(C)N(C)C(C)(C)C4)n3)nc([N+](CCCC)(C3CC(C)(C)N(C)C(C)(C)C3)C3CC(C)(C)N(C)C(C)(C)C3)n2)nc([N+](CCCC)(C2CC(C)(C)N(C)C(C)(C)C2)C2CC(C)(C)N(C)C(C)(C)C2)n1
InChIInChI=1S/C132H252N32/c1-49-57-71-157(73-65-67-133-105-139-111(159(75-59-51-3)97-81-117(9,10)149(41)118(11,12)82-97)145-112(140-105)160(76-60-52-4)98-83-119(13,14)150(42)120(15,16)84-98)109-137-107(143-115(147-109)163(79-63-55-7,101-89-125(25,26)153(45)126(27,28)90-101)102-91-127(29,30)154(46)128(31,32)92-102)135-69-70-136-108-138-110(148-116(144-108)164(80-64-56-8,103-93-129(33,34)155(47)130(35,36)94-103)104-95-131(37,38)156(48)132(39,40)96-104)158(72-58-50-2)74-66-68-134-106-141-113(161(77-61-53-5)99-85-121(17,18)151(43)122(19,20)86-99)146-114(142-106)162(78-62-54-6)100-87-123(21,22)152(44)124(23,24)88-100/h97-104H,49-96H2,1-48H3,(H,133,139,140,145)(H,134,141,142,146)(H,135,137,143,147)(H,136,138,144,148)/q+2
InChIKeyKFQUHJNEPJICPY-UHFFFAOYSA-N
MW2287.69 g/mol
LogP26.02
Rot. Bonds55

About [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium

[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium (PubChem CID 18671065) has the molecular formula C132H252N32+2 and a molecular weight of 2287.69 g/mol. Its IUPAC name is [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium.

Molecular Properties

Compound Name[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium
PubChem CID18671065
Molecular FormulaC132H252N32+2
Molecular Weight2287.69 g/mol
Exact Mass2286.07
IUPAC Name[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium
SMILESCCCCN(CCCNc1nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)n1)c1nc(NCCNc2nc(N(CCCC)CCCNc3nc(N(CCCC)C4CC(C)(C)N(C)C(C)(C)C4)nc(N(CCCC)C4CC(C)(C)N(C)C(C)(C)C4)n3)nc([N+](CCCC)(C3CC(C)(C)N(C)C(C)(C)C3)C3CC(C)(C)N(C)C(C)(C)C3)n2)nc([N+](CCCC)(C2CC(C)(C)N(C)C(C)(C)C2)C2CC(C)(C)N(C)C(C)(C)C2)n1
InChIInChI=1S/C132H252N32/c1-49-57-71-157(73-65-67-133-105-139-111(159(75-59-51-3)97-81-117(9,10)149(41)118(11,12)82-97)145-112(140-105)160(76-60-52-4)98-83-119(13,14)150(42)120(15,16)84-98)109-137-107(143-115(147-109)163(79-63-55-7,101-89-125(25,26)153(45)126(27,28)90-101)102-91-127(29,30)154(46)128(31,32)92-102)135-69-70-136-108-138-110(148-116(144-108)164(80-64-56-8,103-93-129(33,34)155(47)130(35,36)94-103)104-95-131(37,38)156(48)132(39,40)96-104)158(72-58-50-2)74-66-68-134-106-141-113(161(77-61-53-5)99-85-121(17,18)151(43)122(19,20)86-99)146-114(142-106)162(78-62-54-6)100-87-123(21,22)152(44)124(23,24)88-100/h97-104H,49-96H2,1-48H3,(H,133,139,140,145)(H,134,141,142,146)(H,135,137,143,147)(H,136,138,144,148)/q+2
InChIKeyKFQUHJNEPJICPY-UHFFFAOYSA-N
XLogP26.02
TPSA248.16 Ų
H-Bond Donors4
H-Bond Acceptors30
Rotatable Bonds55
Heavy Atoms164
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002287.69
LogP ≤ 526.02
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Analyze [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Antioxidant 119
CID 163763
1,3,5-Triazine-2,4,6-triamine, N2,N2'-1,2-ethanediylbis[N2-[3-[[4,6-bis[butyl(2,2,6,6-tetramethyl-4-piperidinyl)amino]-1,3,5-triazin-2-yl]amino]propyl]-N4,N6-dibutyl-N4,N6-bis(2,2,6,6-tetramethyl-4-piperidinyl)-
CID 160081
2,9,11,13,15,22,24,26,27,28-Decaazatricyclo(21.3.1.110,14)octacosa-1(27),10,12,14(28),23,25-hexaene-12,25-diamine, N12,N25-bis(1,1,3,3-tetramethylbutyl)-2,9,15,22-tetrakis(2,2,6,6-tetramethyl-4-piperidinyl)-
CID 20768156
Methanimidamide, N,N''-(6-(diethylamino)-1,3,5-triazine-2,4-diyl)bis(N,N'-bis(2,2,6,6-tetramethyl-4-piperidinyl)-
CID 163867
2-N-[6-[[4-[6-[[4,6-bis(dibutylamino)-1,3,5-triazin-2-yl]-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-6-[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-4-N,4-N,6-N,6-N-tetrabutyl-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine
CID 20609193
1,3,5-Triazine-2,4,6-triamine, N2,N2-bis(3-((4,6-bis(butyl(2,2,6,6-tetramethyl-4-piperidinyl)amino)-1,3,5-triazin-2-yl)amino)propyl)-N4,N6-dibutyl-N4,N6-bis(2,2,6,6-tetramethyl-4-piperidinyl)-
CID 155024
1,3,5-Triazine-2,4,6-triamine, N,N',N''-tributyl-N,N',N''-tris(2,2,6,6-tetramethyl-4-piperidinyl)-
CID 156239
4-N-butyl-2-N-[6-[[4-[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-6-chloro-1,3,5-triazin-2-yl]-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-6-chloro-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine
CID 21697878
6-N-[3-[2-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl]amino]ethylamino]propyl]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine
CID 22643730
6-N-[3-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl]amino]ethylamino]propyl]-2-N,4-N-dibutyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine
CID 23513079
N2,N2'-(Hexane-1,6-diyl)bis(N4,N6-dibutyl-N2,N4,N6-tris(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine)
CID 57667456
1,3,5-Triazine-2,4,6-triamine, N,N'''-1,2-ethanediylbis(N-(3-((4,6-bis((3-methoxypropyl)(2,2,6,6-tetramethyl-4-piperidinyl)amino)-1,3,5-triazin-2-yl)amino)propyl)-N',N''-bis(3-methoxypropyl)-N',N''-bis(2,2,6,6-tetramethyl-4-piperidinyl)-
CID 102438383

Frequently Asked Questions

What is the IUPAC name of [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium?
The IUPAC name of [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium (CID 18671065) is [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium.
What is the SMILES notation for [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium?
The canonical SMILES for [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium is CCCCN(CCCNc1nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)n1)c1nc(NCCNc2nc(N(CCCC)CCCNc3nc(N(CCCC)C4CC(C)(C)N(C)C(C)(C)C4)nc(N(CCCC)C4CC(C)(C)N(C)C(C)(C)C4)n3)nc([N+](CCCC)(C3CC(C)(C)N(C)C(C)(C)C3)C3CC(C)(C)N(C)C(C)(C)C3)n2)nc([N+](CCCC)(C2CC(C)(C)N(C)C(C)(C)C2)C2CC(C)(C)N(C)C(C)(C)C2)n1.
What is the InChIKey of [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium?
The InChIKey is KFQUHJNEPJICPY-UHFFFAOYSA-N. The full InChI is InChI=1S/C132H252N32/c1-49-57-71-157(73-65-67-133-105-139-111(159(75-59-51-3)97-81-117(9,10)149(41)118(11,12)82-97)145-112(140-105)160(76-60-52-4)98-83-119(13,14)150(42)120(15,16)84-98)109-137-107(143-115(147-109)163(79-63-55-7,101-89-125(25,26)153(45)126(27,28)90-101)102-91-127(29,30)154(46)128(31,32)92-102)135-69-70-136-108-138-110(148-116(144-108)164(80-64-56-8,103-93-129(33,34)155(47)130(35,36)94-103)104-95-131(37,38)156(48)132(39,40)96-104)158(72-58-50-2)74-66-68-134-106-141-113(161(77-61-53-5)99-85-121(17,18)151(43)122(19,20)86-99)146-114(142-106)162(78-62-54-6)100-87-123(21,22)152(44)124(23,24)88-100/h97-104H,49-96H2,1-48H3,(H,133,139,140,145)(H,134,141,142,146)(H,135,137,143,147)(H,136,138,144,148)/q+2.
What are the key properties of [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium?
[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium has a molecular weight of 2287.69 g/mol, XLogP of 26.02, 55 rotatable bonds, 4 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[2-[[4-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]amino]propyl-butylamino]-6-[butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azaniumyl]-1,3,5-triazin-2-yl]amino]ethylamino]-1,3,5-triazin-2-yl]-butyl-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)azanium is sourced from PubChem (CID 18671065), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).